Mark A. Hillman
Hillman Value Fund
Mark A. Hillman Merck & Company Inc stake
total: 75
Hillman Value Fund MRK trades
- Total transactions:
- 6
- New positions:
- 1
- Sold out:
- 1
- Added:
- 3
- Reduced:
- 1
- Held since:
- 2020 Q1
- Held for:
- 11 quarters
- Latest activity:
- 2022 Q4
According to 2026 Q1 report, Mark A. Hillman doesn't hold any Merck & Company Inc (MRK) shares. To date, the estimated cost basis is nearly $78.28 for "buy" trades and estimated average "sell" price is $86.12. Hillman Value Fund first purchased MRK in 2020 Q1, initially acquiring 36,400 shares. Since the initial investment in Merck & Company Inc (MRK), Hillman Value Fund has made 5 more transactions.
When did Mark A. Hillman sell Merck & Company Inc (MRK)?
Mark A. Hillman sold off the entire Merck & Company Inc (MRK) position in 2022 Q4.
When did Mark A. Hillman buy Merck & Company Inc (MRK)?
Mark A. Hillman first invested in Merck & Company Inc (MRK) in 2020 Q1 at the reported quarter-end price of $76.94 per share.
What's the cost basis of Hillman Value Fund's MRK stake?
The estimated cost basis for Merck & Company Inc (MRK) stake is around $78.28 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $78.28
- Weighted AVG sell price:
- $86.12
Mark A. Hillman's historical trades in Merck & Company Inc
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q4
|
0.00%
|
0
|
$86.12
|
|
-100% (-60,169)
|
-2.88%
|
|
2022 Q3
|
2.88%
|
60,169
|
$86.12
|
$5,181,754
|
-33.15% (-29,831)
|
-1.23%
|
|
2021 Q2
|
3.35%
|
90,000
|
$77.77
|
$6,999,300
|
+42.86% (+27,000)
|
+1.01%
|
|
2021 Q1
|
2.81%
|
63,000
|
$77.09
|
$4,856,670
|
+11.70% (+6,600)
|
+0.29%
|
|
2020 Q4
|
3.51%
|
$81.80
|
+54.95% (+20,000)
|
|||
|
2020 Q1
|
3.91%
|
$76.94
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.